The Week at a Glance
Week 28 felt like a collective decision by European mid-market buyers to stop waiting for the perfect macro and just… do deals. With rates still stubborn and valuation gaps still real, the action shifted toward transactions you can underwrite: carve-outs, roll-ups, and platform buys with clear levers.
Two forces dominated: (1) exit urgency (hello, backlog) pushing sponsors to monetize what they can, and (2) AI’s “real economy” phase, where services, infrastructure and applied vertical tools get funded while pure-play software multiples stay on a diet. The result was a week where healthcare and tech both showed up—just not always in the way the 2021 pitch decks promised.
What's Moving the Market
Europe’s mid-market is picking up speed into H2 2026, with projected deal volumes up 16% and sentiment sitting at 96—but nobody’s pretending financing is easy. Persistent interest rates are still forcing buyers to be honest about cash flow, covenants, and what “synergies” really means once the integration bill arrives.
First macro driver: credit dynamics and exit pressure. The exit backlog isn’t a headline; it’s a workflow problem. Sponsors need DPI, and that’s pushing more pragmatic outcomes: management buyouts like Peugeot Motocycles, sponsor-to-sponsor moves like TFP Fertility, and take-privates such as Idox.
Second: AI-driven sector realignment. Capital is flowing to AI enablement (services, infrastructure, hardware), while traditional software M&A remains cooler and more valuation-sensitive—seen in funding for Ethos and deep-tech bets like QuantWare.
Deal of the Week
Lone Star buys RadiciGroup’s chemicals and polymers units — a classic “hard assets, hard work, hard to replicate” play that fits 2026’s mid-market mood perfectly. The acquisition of RadiciGroup’s divisions in Italy by Lone Star (Lone Star/RadiciGroup) isn’t about chasing a frothy multiple; it’s about buying complexity and then getting paid to simplify it.Carve-outs and divisional separations are back in fashion because they create their own value-creation plan: stand up systems, rationalize SKUs, fix procurement, and reframe the business for either a strategic exit or a more financeable standalone profile. In a rate environment that punishes “trust me” underwriting, this is the kind of transaction where the playbook is legible.
Also, Italy continues to quietly overdeliver on deal flow—often via corporate portfolios that are ready (or forced) to be re-shaped. If you’re a sponsor staring at an aging portfolio and an impatient IC, carve-outs like this are one of the few places you can still manufacture both growth and liquidity.
Exit Pressure Meets Practical Buyers
If Week 28 had a tagline, it would be: “DPI is a strategy.” Sponsors are clearing the exit backlog where they can, even if the path isn’t glamorous.
Start with healthcare: Benefit Street’s exit of TFP Fertility Group to Amulet Capital is a reminder that specialist healthcare platforms still clear—because demand is structural, and operational levers are tangible. Consumer exits also ticked up: MBK exploring a sale of Pierre Marcolini signals buyers still want premium brands, just with tighter underwriting on margin durability (cocoa isn’t getting cheaper). And in Spain, Growth Partner exiting Synergym is the kind of “take the win” outcome you’ll see more of as funds triage liquidity.
Then there’s the “least dramatic exit” award: Mutares selling Peugeot Motocycles to management. It’s not a fireworks outcome, but it’s often the cleanest way to get a deal done when financing and buyer appetite don’t align.
Finally, take-privates are creeping in as a release valve. Long Path’s acquisition of Idox shows the public-to-private route remains viable for unloved small caps—especially where recurring revenues can be stabilized away from quarterly scrutiny.
AI Grows Up: Services, Hardware, and “Applied” Wins
The AI trade in Week 28 looked less like “buy SaaS at any price” and more like “fund the picks-and-shovels and the adults who can implement them.”
On the services side, Ethos raising EUR 21.06m from a heavyweight group is the tell: enterprises don’t need another demo; they need deployment, governance, and change management. That’s also why healthcare advisory keeps attracting capital—Baird backing Blue Matter fits the same pattern of services-led value capture in complex buyer environments.
On the hardware/deep-tech end, QuantWare pulling in EUR 152m (with Intel Capital among backers) signals renewed appetite for infrastructure-grade bets—long duration, yes, but strategically scarce if it works. And if you want a reminder that late-stage checks still exist, the UK produced two monster rounds: Ineffable Intelligence at EUR 1,018.52m and Finland’s Oura Health at EUR 833.33m.
Meanwhile, corporate buyers are still picking off capability. SAP’s acquisition of Prior Labs is light on disclosed rationale so far, but the direction is consistent: large incumbents buying specific talent/tech wedges rather than betting on broad platform M&A.
The subtext: mid-market software isn’t dead—it’s just being re-underwritten. The winners are the ones tied to implementation, data, or regulated verticals, not “we added an AI button.”
Consolidation Nation (Brokers, Building Services, Fleet, and Warehouses)
Fragmentation is the mid-market’s renewable resource, and Week 28 brought plenty of roll-up logic.
In Italy, insurtech Wopta bought Zanni Broker and GM Insurance Brokers for EUR 5m, adding distribution to product. It’s a familiar play: control the channel, improve unit economics, then decide whether you’re a tech company or a brokerage group (spoiler: you’ll be valued like whichever one you can prove in financial statements). In the UK, Laka’s acquisition of VeloLife’s bike insurance book is a smaller but telling datapoint: specialty insurance books are becoming the bolt-on of choice because they bring immediate premium volume and data.
In “things that need fixing and checking,” Ansor-backed Complii acquiring Classic Lifts Scotland is more evidence that building-services maintenance remains PE catnip: recurring service revenue, local density, and operational upside. Add industrial carve-out activity like Hypax buying Metra Non-Ferrous Metals, and the theme is consistent—buy fragmented or non-core assets, then professionalize.
In tech-enabled ops, Cinven’s investment in Ongoing Warehouse and Norvestor’s move for Germany’s Debtist point to sponsors preferring mission-critical workflows over “nice-to-have” SaaS. And Netradyne acquiring Germany’s Moove Connected Mobility shows US buyers still see Europe as an expansion market—especially where regulation and fleet structure create moats once you’re established.
By the Numbers
- 28 deals tracked (+4% vs 4-week avg) — activity is broadening as H2 ramps.
- EUR 2,838m disclosed volume (-22% vs 4-week avg) — fewer mega disclosed tickets despite a couple of eye-catching rounds.
- 9 deals with disclosed amounts — disclosure remains the exception, not the rule (mid-market opacity undefeated).
- Deal mix: 15 acquisitions, 10 fundings, 3 exits — still buyer-led, with exits gradually reappearing.
- Sector leaders: Other (9), Technology (5), Healthcare (4), Financial Services (3) — “Other” is doing a lot of work, but the underlying pattern is services + industrial + infra.
- Most active geographies: GB (9) and IT (6) lead, followed by DE (3) — the UK is still Europe’s mid-market deal factory.
- Top disclosed deal (by provided stats): QuantWare EUR 152m — deep tech is back on the menu.
On Our Radar
Next week’s question: does the exit backlog finally force more creative structures—continuation vehicles, partial sells, and corporate carve-out partnerships—or do we just get more “clean” sponsor-to-sponsor trades like TFP Fertility? Also watch Italy: between Banca Sistema, RadiciGroup, and steady consolidation deals, it’s turning into the most reliable source of actionable mid-market situations.
And one more: UK fintech funding is sliding (UK fintech funding). If capital is rationed, expect more acqui-hires, book purchases, and “merge to survive” conversations—because runway math is the most persuasive pitch deck of all.